1 code implementation • 14 Mar 2024 • Hong Liu, Haosen Yang, Paul J. van Diest, Josien P. W. Pluim, Mitko Veta
In particular, our model outperforms SAM by 4. 1 and 2. 5 percent points on a ductal carcinoma in situ (DCIS) segmentation tasks and breast cancer metastasis segmentation task (CAMELYON16 dataset).
no code implementations • 7 Oct 2020 • Suzanne C. Wetstein, Nikolas Stathonikos, Josien P. W. Pluim, Yujing J. Heng, Natalie D. ter Hoeve, Celien P. H. Vreuls, Paul J. van Diest, Mitko Veta
In conclusion, we developed a deep learning-based DCIS grading system that achieved a performance similar to expert observers.
no code implementations • 22 Jul 2018 • Mitko Veta, Yujing J. Heng, Nikolas Stathonikos, Babak Ehteshami Bejnordi, Francisco Beca, Thomas Wollmann, Karl Rohr, Manan A. Shah, Dayong Wang, Mikael Rousson, Martin Hedlund, David Tellez, Francesco Ciompi, Erwan Zerhouni, David Lanyi, Matheus Viana, Vassili Kovalev, Vitali Liauchuk, Hady Ahmady Phoulady, Talha Qaiser, Simon Graham, Nasir Rajpoot, Erik Sjöblom, Jesper Molin, Kyunghyun Paeng, Sangheum Hwang, Sunggyun Park, Zhipeng Jia, Eric I-Chao Chang, Yan Xu, Andrew H. Beck, Paul J. van Diest, Josien P. W. Pluim
The best performing automatic method for the first task achieved a quadratic-weighted Cohen's kappa score of $\kappa$ = 0. 567, 95% CI [0. 464, 0. 671] between the predicted scores and the ground truth.
no code implementations • 20 Jun 2016 • Mitko Veta, Paul J. van Diest, Josien P. W. Pluim
We hypothesize that given an image of a tumor region with known nuclei locations, the area of the individual nuclei and region statistics such as the MNA can be reliably computed directly from the image data by employing a machine learning model, without the intermediate step of nuclei segmentation.
no code implementations • 21 Nov 2014 • Mitko Veta, Paul J. van Diest, Stefan M. Willems, Haibo Wang, Anant Madabhushi, Angel Cruz-Roa, Fabio Gonzalez, Anders B. L. Larsen, Jacob S. Vestergaard, Anders B. Dahl, Dan C. Cireşan, Jürgen Schmidhuber, Alessandro Giusti, Luca M. Gambardella, F. Boray Tek, Thomas Walter, Ching-Wei Wang, Satoshi Kondo, Bogdan J. Matuszewski, Frederic Precioso, Violet Snell, Josef Kittler, Teofilo E. de Campos, Adnan M. Khan, Nasir M. Rajpoot, Evdokia Arkoumani, Miangela M. Lacle, Max A. Viergever, Josien P. W. Pluim
The proliferative activity of breast tumors, which is routinely estimated by counting of mitotic figures in hematoxylin and eosin stained histology sections, is considered to be one of the most important prognostic markers.